the use of gtx 102, an aso as a potential therapeutic for angelman syndrome dr scott stromatt 2020
Published 3 years ago • 385 plays • Length 6:30Download video MP4
Download video MP3
Similar videos
-
17:45
the use of gtx 102, an aso as a potential therapeutic for angelman syndrome dr berry-kravis
-
19:24
genetx biotherapeutics: gtx 102 phase 1/2 clinical trial update
-
34:24
2019 fast summit on angelman syndrome - aso for potential treatment of as - genetx biotherapeutics
-
24:51
2019 fast summit on angelman syndrome - aso therapy for as - dr. frank bennett, ionis pharmaceutical
-
20:34
updates on the development of an aso therapy for angelman syndrome dr becky crean 2020 fast scienc
-
16:31
genetx webinar
-
5:12
program update on hematopoietic stem cell gene therapy for angelman syndrome dr joe anderson 2020
-
24:46
rebecca crean | 2022 fast summit on angelman syndrome
-
17:11
open book with fast (foundation for angelman syndrome therapeutics)
-
42:36
emil kakkis | 2022 fast summit on angelman syndrome
-
22:05
benefits:challenges of human cerebral organoids for angelman syndrome research dr albert keung 202
-
32:50
brenda vincenzi | 2022 fast summit on angelman syndrome
-
25:02
learnings guiding clinical trial design for heterogenous populations dr emil kakkis 2020 fast
-
51:08
2019 fast science summit on angelman syndrome - keynote, dr. emil kakkis, ultragenyx pharmaceutical
-
19:52
validation of orca outcome measure dr bryce reeve 2020 fast science summit
-
24:04
présentation des résultats intermédiaires de l’aso gtx-102 au congrès scientifique de fast 2020
-
1:45:49
asf virtualpalooza session 1: pharma updates (7/27/2020)
-
1:54
how was angioplex technology developed and how does it work?